Skip to main content
Erschienen in: European Radiology 8/2020

24.03.2020 | Gastrointestinal

Pseudomyxoma peritonei: visceral scalloping on CT is a predictor of recurrence after complete cytoreductive surgery

verfasst von: Masatoshi Hotta, Ryogo Minamimoto, Yoshimasa Gohda, Tsuyoshi Tajima, Tomomichi Kiyomatsu, Hideaki Yano

Erschienen in: European Radiology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Pseudomyxoma peritonei (PMP) is characterized by peritoneal dissemination of gelatinous ascites following rupture of a mucinous tumor. Treatment by cytoreductive surgery (CRS) has improved its prognosis. Although visceral scalloping, notably liver scalloping, on computed tomography (CT) is a typical feature of PMP, its prognostic value remains unknown. We aimed to investigate the efficacy of liver scalloping in predicting recurrence in PMP patients.

Methods

Among 159 consecutive patients with PMP who had contrast-enhanced CT between September 2012 and December 2018, 64 treatment-naïve patients who subsequently underwent CRS with complete resection (i.e., completeness of cytoreduction score (CC)-0 or CC-1), were included in analysis. Presence of liver scalloping and maximum thickness of mucin deposition at the liver surface were evaluated on CT. Disease-free survival (DFS) was determined based on the combination of postoperative CT features and tumor marker values.

Results

Median follow-up was 24.3 months. CT revealed liver scalloping in 40/64 (63.4%) patients. Kaplan–Meier analysis showed significantly shorter DFS in patients with scalloping than in those without (p = 0.001; hazard ratio, 4.3). In patients with scalloping, greater mucin deposition (thickness ≥ 20 mm) significantly correlated with poorer DFS (p = 0.042). In multivariate Cox proportional hazards regression including CC status, pathologic type, and tumor markers, the presence of scalloping independently and significantly correlated with DFS (p = 0.031).

Conclusions

Liver scalloping was an independent predictor even after adjusting for clinical covariates. The presence of liver scalloping can lead to a high recurrence rate after CRS.

Key Points

• The presence of liver scalloping is a prognostic factor independent of histological grade and tumor markers.
• Greater mucin deposition (thickness ≥ 20 mm at the liver surface) is associated with higher recurrence rates in patients with liver scalloping.
Literatur
1.
Zurück zum Zitat Smeenk RM, Verwaal VJ, Zoetmulder FA (2007) Pseudomyxoma peritonei. Cancer Treat Rev 33:138–145CrossRef Smeenk RM, Verwaal VJ, Zoetmulder FA (2007) Pseudomyxoma peritonei. Cancer Treat Rev 33:138–145CrossRef
2.
Zurück zum Zitat Mukherjee A, Parvaiz A, Cecil TD, Moran BJ (2004) Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur J Gynaecol Oncol 25:411–414PubMed Mukherjee A, Parvaiz A, Cecil TD, Moran BJ (2004) Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur J Gynaecol Oncol 25:411–414PubMed
3.
Zurück zum Zitat Ansari N, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol 42:1035–1041CrossRef Ansari N, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol 42:1035–1041CrossRef
4.
Zurück zum Zitat Witkamp AJ, de Bree E, Kaag MM et al (2001) Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 37:979–984CrossRef Witkamp AJ, de Bree E, Kaag MM et al (2001) Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 37:979–984CrossRef
5.
Zurück zum Zitat Huang CQ, Min Y, Wang SY et al (2017) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence. Oncotarget 8:55657–55683CrossRef Huang CQ, Min Y, Wang SY et al (2017) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence. Oncotarget 8:55657–55683CrossRef
6.
Zurück zum Zitat Yan TD, Deraco M, Baratti D et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237–6242CrossRef Yan TD, Deraco M, Baratti D et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237–6242CrossRef
7.
Zurück zum Zitat Chua TC, Moran BJ, Sugarbaker PH et al (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456CrossRef Chua TC, Moran BJ, Sugarbaker PH et al (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456CrossRef
8.
Zurück zum Zitat Fonseca E, Martins AN, Tridente CF, Yamauchi FI, Baroni RH (2017) Liver scalloping in pseudomyxoma peritonei. Abdom Radiol (NY) 42:2003–2004CrossRef Fonseca E, Martins AN, Tridente CF, Yamauchi FI, Baroni RH (2017) Liver scalloping in pseudomyxoma peritonei. Abdom Radiol (NY) 42:2003–2004CrossRef
9.
Zurück zum Zitat Sulkin TV, O'Neill H, Amin AI, Moran B (2002) CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol 57:608–613CrossRef Sulkin TV, O'Neill H, Amin AI, Moran B (2002) CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol 57:608–613CrossRef
10.
Zurück zum Zitat Seshul MB, Coulam CM (1981) Pseudomyxoma peritonei: computed tomography and sonography. AJR Am J Roentgenol 136:803–806CrossRef Seshul MB, Coulam CM (1981) Pseudomyxoma peritonei: computed tomography and sonography. AJR Am J Roentgenol 136:803–806CrossRef
11.
Zurück zum Zitat Hotta M, Minamimoto R, Gohda Y, Igari T, Yano H (2019) Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei. Eur Radiol 29:5709–5716CrossRef Hotta M, Minamimoto R, Gohda Y, Igari T, Yano H (2019) Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei. Eur Radiol 29:5709–5716CrossRef
12.
Zurück zum Zitat Carr NJ, Cecil TD, Mohamed F et al (2016) A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process. Am J Surg Pathol 40:14–26CrossRef Carr NJ, Cecil TD, Mohamed F et al (2016) A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process. Am J Surg Pathol 40:14–26CrossRef
13.
Zurück zum Zitat Passot G, Kim BJ, Vaudoyer D et al (2016) Digital Glissonectomy: a safe perihepatic peritonectomy. Ann Surg Oncol 23:3978–3985CrossRef Passot G, Kim BJ, Vaudoyer D et al (2016) Digital Glissonectomy: a safe perihepatic peritonectomy. Ann Surg Oncol 23:3978–3985CrossRef
14.
Zurück zum Zitat Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–731CrossRef Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–731CrossRef
15.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef
16.
Zurück zum Zitat Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH (1995) Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181:530–538PubMed Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH (1995) Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181:530–538PubMed
17.
Zurück zum Zitat Menassel B, Duclos A, Passot G et al (2016) Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms. Eur J Surg Oncol 42:558–566CrossRef Menassel B, Duclos A, Passot G et al (2016) Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms. Eur J Surg Oncol 42:558–566CrossRef
18.
Zurück zum Zitat Bouquot M, Dohan A, Gayat E et al (2018) Prediction of resectability in pseudomyxoma peritonei with a new CT score. Ann Surg Oncol 25:694–701CrossRef Bouquot M, Dohan A, Gayat E et al (2018) Prediction of resectability in pseudomyxoma peritonei with a new CT score. Ann Surg Oncol 25:694–701CrossRef
19.
Zurück zum Zitat Flicek K, Ashfaq A, Johnson CD, Menias C, Bagaria S, Wasif N (2016) Correlation of radiologic with surgical peritoneal cancer index scores in patients with pseudomyxoma peritonei and peritoneal carcinomatosis: how well can we predict resectability? J Gastrointest Surg 20:307–312CrossRef Flicek K, Ashfaq A, Johnson CD, Menias C, Bagaria S, Wasif N (2016) Correlation of radiologic with surgical peritoneal cancer index scores in patients with pseudomyxoma peritonei and peritoneal carcinomatosis: how well can we predict resectability? J Gastrointest Surg 20:307–312CrossRef
20.
Zurück zum Zitat Chua TC, Al-Zahrani A, Saxena A et al (2011) Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 18:1582–1589CrossRef Chua TC, Al-Zahrani A, Saxena A et al (2011) Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 18:1582–1589CrossRef
21.
Zurück zum Zitat Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH (2003) Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 22:465–472CrossRef Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH (2003) Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 22:465–472CrossRef
22.
Zurück zum Zitat Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ (2014) Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei: analysis of 519 patients. Eur J Surg Oncol 40:515–520CrossRef Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ (2014) Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei: analysis of 519 patients. Eur J Surg Oncol 40:515–520CrossRef
23.
Zurück zum Zitat Chua TC, Chong CH, Liauw W, Zhao J, Morris DL (2012) Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy. Ann Surg 256:342–349CrossRef Chua TC, Chong CH, Liauw W, Zhao J, Morris DL (2012) Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy. Ann Surg 256:342–349CrossRef
24.
Zurück zum Zitat Low RN, Barone RM, Lucero J (2015) Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 22:1708–1715CrossRef Low RN, Barone RM, Lucero J (2015) Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 22:1708–1715CrossRef
25.
Zurück zum Zitat Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ (2015) Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Eur J Surg Oncol 41:396–399CrossRef Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ (2015) Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Eur J Surg Oncol 41:396–399CrossRef
26.
Zurück zum Zitat Mercier F, Dagbert F, Pocard M et al (2019) Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open 3:195–202CrossRef Mercier F, Dagbert F, Pocard M et al (2019) Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open 3:195–202CrossRef
Metadaten
Titel
Pseudomyxoma peritonei: visceral scalloping on CT is a predictor of recurrence after complete cytoreductive surgery
verfasst von
Masatoshi Hotta
Ryogo Minamimoto
Yoshimasa Gohda
Tsuyoshi Tajima
Tomomichi Kiyomatsu
Hideaki Yano
Publikationsdatum
24.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06756-2

Weitere Artikel der Ausgabe 8/2020

European Radiology 8/2020 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.